EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features

被引：0
|
作者：
Dundar, Bilge [1 ]
Sompallae, Ramakrishna [2 ]
Guseva, Natalya [1 ]
Bossler, Aaron [1 ]
Ma, Deqin [2 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1199
引用
收藏
页码：1299 / 1301
页数：3
相关论文
共 50 条
  • [41] A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer
    Hu, Song
    Ming, Hao
    He, Qian
    Ding, Ming
    Ding, Hao
    Li, Chong
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] Amivantamab: a monoclonal EGFR-MET bispecific antibody for EGFR exon 20 insertion in non-small cell lung cancer
    Xie, Yuhao
    Lu, Qisi
    Wang, Jing-Quan
    Bo, Letao
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    [J]. DRUGS OF TODAY, 2022, 58 (08) : 389 - 398
  • [43] Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
    Wang, Mengzhao
    Yang, James Chih-Hsin
    Mitchell, Paul L.
    Fang, Jian
    Camidge, D. Ross
    Nian, Weiqi
    Chiu, Chao-Hua
    Zhou, Jianying
    Zhao, Yanqiu
    Su, Wu-Chou
    Yang, Tsung-Ying
    Zhu, Viola W.
    Millward, Michael
    Fan, Yun
    Huang, Wen-Tsung
    Cheng, Ying
    Jiang, Liyan
    Brungs, Daniel
    Bazhenova, Lyudmila
    Lee, Chee Khoon
    Gao, Bo
    Xu, Yan
    Hsu, Wei-Hsun
    Zheng, Li
    Janne, Pasi A.
    [J]. CANCER DISCOVERY, 2022, 12 (07) : 1676 - 1689
  • [44] Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
    Gao, Xin
    Wei, Xue-Wu
    Zheng, Ming-Ying
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Zhong, Wen-Zhao
    Yang, Jin-Ji
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5822 - +
  • [45] Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options
    Brazel, Danielle
    Kroening, Gianna
    Nagasaka, Misako
    [J]. BIODRUGS, 2022, 36 (06) : 717 - 729
  • [46] Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options
    Danielle Brazel
    Gianna Kroening
    Misako Nagasaka
    [J]. BioDrugs, 2022, 36 : 717 - 729
  • [47] Advances in the Diagnosis and Treatment of Advanced Non-Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
    Liu, Jingwen
    Xiang, Yan
    Fang, Tingwen
    Zeng, Lulin
    Sun, Ao
    Lin, Yixiang
    Lu, Kaihua
    [J]. CLINICAL LUNG CANCER, 2024, 25 (02) : 100 - 108
  • [48] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
    Jiabao Hou
    Hongle Li
    Shuxiang Ma
    Zhen He
    Sen Yang
    Lidan Hao
    Hanqiong Zhou
    Zhe Zhang
    Jing Han
    Li Wang
    Qiming Wang
    [J]. Biomarker Research, 10
  • [49] EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
    Hou, Jiabao
    Li, Hongle
    Ma, Shuxiang
    He, Zhen
    Yang, Sen
    Hao, Lidan
    Zhou, Hanqiong
    Zhang, Zhe
    Han, Jing
    Wang, Li
    Wang, Qiming
    [J]. BIOMARKER RESEARCH, 2022, 10 (01)
  • [50] EGFR Exon 20 insertion: Prognostic and predictive values in advanced non-small cell lung cancer, a real-world study.
    Chouaid, Christos
    Filleron, Thomas
    Debieuvre, Didier
    Perol, Maurice
    Girard, Nicolas
    Dansin, Eric
    Gervais, Radj
    Cousin, Sophie
    Otto, Josiane
    Schott, Roland
    Planchard, David
    Madroszyk, Anne
    Kaderbhai, Coureche
    Dubray-Longeras, Pascale
    Hiret, Sandrine
    Pichon, Eric
    Clement-Duchene, Christelle Anne
    Martin, Anne-Laure
    Simon, Gaetane
    Quantin, Xavier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345